Zymeworks Stock-Based Compensation Growth & History (ZYME)
Zymeworks's stock-based compensation was $28.0M for fiscal 2025.
View full Zymeworks company overviewZymeworks annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $28.0M | $10.2M | +57.57% |
| 2024 | 2024-12-31 | $17.8M | $9.7M | +119.60% |
| 2023 | 2023-12-31 | $8.1M | $4.1M | +101.79% |
| 2022 | 2022-12-31 | $4.0M | −$6.7M | −62.67% |
| 2021 | 2021-12-31 | $10.8M | −$18.4M | −63.06% |
| 2020 | 2020-12-31 | $29.1M | — | — |
Zymeworks quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.3M | $5.5M | +93.05% |
| Q1 2026 | 2026-03-31 | $6.9M | $533,000 | +8.33% |
| Q4 2025 | 2025-12-31 | $8.8M | $3.8M | +76.26% |
| Q3 2025 | 2025-09-30 | $6.9M | $2.2M | +48.18% |
| Q2 2025 | 2025-06-30 | $5.9M | $1.3M | +28.89% |
| Q1 2025 | 2025-03-31 | $6.4M | $2.9M | +80.24% |
| Q4 2024 | 2024-12-31 | $5.0M | $1.7M | +48.99% |
| Q3 2024 | 2024-09-30 | $4.7M | $2.6M | +128.63% |
| Q2 2024 | 2024-06-30 | $4.6M | $4.2M | +1141.14% |
| Q1 2024 | 2024-03-31 | $3.6M | $1.2M | +52.77% |
| Q4 2023 | 2023-12-31 | $3.4M | −$1.1M | −25.08% |
| Q3 2023 | 2023-09-30 | $2.0M | −$2.8M | −57.49% |
| Q2 2023 | 2023-06-30 | $367,000 | −$2.5M | −87.32% |
| Q1 2023 | 2023-03-31 | $2.3M | $10.5M | — |
| Q4 2022 | 2022-12-31 | $4.5M | — | — |
| Q3 2022 | 2022-09-30 | $4.8M | — | — |
| Q2 2022 | 2022-06-30 | $2.9M | — | — |
| Q1 2022 | 2022-03-31 | −$8.2M | — | — |
Zymeworks stock-based compensation trends
Over the last five fiscal years, Zymeworks's stock-based compensation decreased from $29.1M to $28.0M, a change of −$1.1M. The latest reported quarter, Q2 2026, shows $11.3M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zymeworks source filings ↗